{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T11:46:44Z","timestamp":1717069604401},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,10,29]],"date-time":"2005-10-29T00:00:00Z","timestamp":1130544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Biophys J"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00249-005-0026-6","type":"journal-article","created":{"date-parts":[[2005,10,31]],"date-time":"2005-10-31T16:44:06Z","timestamp":1130777046000},"page":"125-135","source":"Crossref","is-referenced-by-count":9,"title":["Computational studies on class I ribonucleotide reductase: understanding the mechanisms of action and inhibition of a cornerstone enzyme for the treatment of cancer"],"prefix":"10.1007","volume":"35","author":[{"given":"Susana","family":"Pereira","sequence":"first","affiliation":[]},{"given":"Nuno M.F.S.A.","family":"Cerqueira","sequence":"additional","affiliation":[]},{"given":"Pedro Alexandrino","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Ramos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2005,10,29]]},"reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0163-7258(00)00050-4","volume":"87","author":"J Balzarini","year":"2000","unstructured":"Balzarini J (2000) Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors. Pharmacol Ther 87:175\u2013187","journal-title":"Pharmacol Ther"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1021\/ja00097a008","volume":"116","author":"JM Bollinger Jr","year":"1994","unstructured":"Bollinger JM Jr, Tong WH, Ravi N, Huynh BH, Edmonson DE, Stubbe J (1994) Mechanism of assembly of the tyrosyl radical-diiron(III) cofactor of E. coli ribonucleotide reductase. 2. Kinetics of the excess Fe2+ reaction by optical, EPR, and M\u00f6ssbauer spectroscopies. J Am Chem Soc 116:8015\u20138023","journal-title":"J Am Chem Soc"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"12910","DOI":"10.1021\/ja9824270","volume":"120","author":"D Burdi","year":"1998","unstructured":"Burdi D, Willems J-P, Riggs-Gelasco P, Antholine WE, Stubbe J, Hoffman BM (1998) The core structure of X generated in the assembly of the diiron cluster of ribonucleotide reductase: 17O2 and H 2 17 O ENDOR. J Am Chem Soc 120:12910\u201312919","journal-title":"J Am Chem Soc"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.theochem.2003.10.073","volume":"709","author":"NMFSA Cerqueira","year":"2004","unstructured":"Cerqueira NMFSA, Femandes PA, Eriksson LA, Ramos MJ (2004a) New insights into a critical biological control step of the mechanism of Ribonucleotide reductase. J Mol Struct (Theochem) 709:53\u201365","journal-title":"J Mol Struct (Theochem)"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/jcc.20127","volume":"25","author":"NMFSA Cerqueira","year":"2004","unstructured":"Cerqueira NMFSA, Fernandes PA, Eriksson LA, Ramos MJ (2004b) Ribonucleotide activation by enzyme ribonucleotide reductase: understanding the role of the enzyme. J Comp Chem 25:2031\u20132037","journal-title":"J Comp Chem"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2174\/0929867054020981","volume":"12","author":"NMFSA Cerqueira","year":"2005","unstructured":"Cerqueira NMFSA, Pereira S, Fernandes PA, Ramos MJ (2005) Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy. Curr Med Chem 12:1283\u20131294","journal-title":"Curr Med Chem"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0969-2126(97)00259-1","volume":"5","author":"M Eriksson","year":"1997","unstructured":"Eriksson M, Uhlin U, Ramaswamy S, Ekberg M, Regnstr\u00f6m K, Sj\u00f6berg B-M, Eklund H (1997) Binding of allosteric effectors to ribonucleotide reductase protein R1: reduction of active-site cysteines promotes substrate binding. Structure 5:1077\u20131092","journal-title":"Structure"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1002\/chem.200304948","volume":"9","author":"PA Fernandes","year":"2003","unstructured":"Fernandes PA, Ramos MJ (2003a) Theoretical studies on the mode of inhibition of ribonucleotide reductase by 2\u2019-substituted substrate analogues. Chem Eur J 9:5916\u20135925","journal-title":"Chem Eur J"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1021\/ja0208613","volume":"125","author":"PA Fernandes","year":"2003","unstructured":"Fernandes PA, Ramos MJ (2003b) Theoretical studies on the mechanism of inhibition of ribonucleotide reductase by (E)-2\u2019-fluoromethylene-2\u2019-deoxycitidine-5\u2019-diphosphate. J Am Chem Soc 125:6311\u20136322","journal-title":"J Am Chem Soc"},{"key":"26_CR10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00214-002-0393-3","volume":"108","author":"PA Fernandes","year":"2002","unstructured":"Fernandes PA, Eriksson LA, Ramos MJ (2002) The reduction of ribonucleotides catalyzed by the enzyme ribonucleotide reductase. Theor Chem Acc 108:352\u2013364","journal-title":"Theor Chem Acc"},{"key":"26_CR11","unstructured":"Fritscher J, Artin E, Wnuk S, Bar B, Robblee JH, Kacprzak S, Kaupp M, Griffin RG, Bennati M, Stubbe J (2005) J Am Chem Soc, Article ASAP. DOI 10.1021\/ja043111x"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/ic020465l","volume":"42","author":"WG Han","year":"2003","unstructured":"Han WG, Lovell T, Liu TQ, Noodleman L, (2003) A density functional evaluation of an Fe(III)-Fe(IV) model diiron cluster: Comparisons with ribonucleotide reductase intermediate X. Inorg Chem 42:2751\u20132758","journal-title":"Inorg Chem"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/ic0206443","volume":"43","author":"WG Han","year":"2004","unstructured":"Han WG, Lovell T, Liu TQ, Noodleman L (2004) Density functional study of a mu-1,1-carboxylate bridged Fe(III)-O-Fe(IV) model complex. 2. Comparison with ribonucleotide reductase intermediate X. Inorg Chem 43:613\u2013621","journal-title":"Inorg Chem"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0006-2952(91)90033-2","volume":"42","author":"JA Harrington","year":"1991","unstructured":"Harrington JA, Spector T (1991) Human ribonucleotide reductase. Activation and inhibition by analogs of ATP. Biochem Pharmacol 42:759\u2013763","journal-title":"Biochem Pharmacol"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1021\/jp000752f","volume":"104","author":"F Himo","year":"2000","unstructured":"Himo F, Siegbahn PEM (2000) Very stable ribonucleotide substrate radical relevant for class I ribonucleotide reductase. J Phys Chem B 104:7502\u20137509","journal-title":"J Phys Chem B"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1021\/cr020436s","volume":"103","author":"F Himo","year":"2003","unstructured":"Himo F, Siegbahn PEM (2003) Quantum chemical studies of radical-containing enzymes. Chem Rev 103:2421\u20132456","journal-title":"Chem Rev"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0169-4758(99)01478-7","volume":"15","author":"GM Ingram","year":"1999","unstructured":"Ingram GM, Kinnaird JH (1999) Ribonucleotide reductase: a new target for antiparasite therapies. Parasitol Today 15:338\u2013342","journal-title":"Parasitol Today"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0006-2952(97)00664-3","volume":"55","author":"DG Johns","year":"1998","unstructured":"Johns DG, Gao WY (1998) Selective depletion of DNA precursors: an evolving strategy for potentiation of dideoxynucleoside activity against human immunodeficiency virus. Biochem Pharmacol 55:1551\u20131556","journal-title":"Biochem Pharmacol"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1074\/jbc.M106538200","volume":"277","author":"A Kasrayan","year":"2002","unstructured":"Kasrayan A, Persson AL, Sahlin M, Sj\u00f6berg B-M (2002) The conserved active site asparagine in class I ribonucleotide reductase is essential for catalysis. J Biol Chem 277:5749\u20135755","journal-title":"J Biol Chem"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1073\/pnas.96.16.8979","volume":"96","author":"CC Lawrence","year":"1999","unstructured":"Lawrence CC, Obias H, Stubbe J, Bennati M, Bar G, Grifin RG (1999) High-field EPR detection of a disulfide radical anion in the reduction of cytidine 5\u2019-diphosphate by the E441Q R1 mutant of Escherichia coli ribonucleotide reductase. Proc Natl Acad Sci USA 96:8979\u20138984","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0969-2126(96)00112-8","volume":"4","author":"DT Logan","year":"1996","unstructured":"Logan DT, Su X-D, \u00c5berg A, Regnstr\u00f6m K, Hadju J, Eklund H, Nordlund P (1996) Crystal structure of reduced protein R2 of ribonucleotide reductase: the structural basis for oxygen activation at a dinuclear iron site. Structure 4:1053\u20131064","journal-title":"Structure"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/14737140.4.3.345","volume":"4","author":"C Manegold","year":"2004","unstructured":"Manegold C (2004) Gemcitabine (Gemzar) in non-small cell lung cancer. Expert Rev Anticancer Ther 4:345\u2013360","journal-title":"Expert Rev Anticancer Ther"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/cr020625a","volume":"104","author":"L Noodleman","year":"2004","unstructured":"Noodleman L, Lovell T, Han WG, Li J, Himo F. (2004) Quantum chemical studies of intermediates and reaction pathways in selected enzymes and catalytic synthetic systems. Chem Rev 104:459\u2013508","journal-title":"Chem Rev"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/345593a0","volume":"345","author":"P Nordlund","year":"1990","unstructured":"Nordlund P, Sj\u00f6berg B-M, Eklund H (1990) 3-Dimensional structure of the free radical protein of ribonucleotide reductase. Nature 345:593\u2013598","journal-title":"Nature"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/jmbi.1993.1374","volume":"232","author":"P Nordlund","year":"1993","unstructured":"Nordlund P, Eklund H (1993) Structure and function of the Escherichia coli ribonucleotide reductase protein R2. J Mol Biol 232:123","journal-title":"J Mol Biol"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jcc.10389","volume":"25","author":"V Pelmenschikov","year":"2004","unstructured":"Pelmenschikov V, Cho KB, Siegbahn PEM (2004) Class I ribonucleotide reductase revisited: the effect of removing a proton on Glu441. J Comp Chem 25:311\u2013321","journal-title":"J Comp Chem"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcc.10375","volume":"25","author":"S Pereira","year":"2004","unstructured":"Pereira S, Fernandes PA, Ramos MJ (2004a) Theoretical study of ribonucleotide reductase mechanism-based inhibition by 2\u2019-azido-2\u2019-deoxyribonucleoside-5\u2019-diphosphates. J Comp Chem 25:227\u2013237","journal-title":"J Comp Chem"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/jcc.20054","volume":"25","author":"S Pereira","year":"2004","unstructured":"Pereira S, Fernandes PA, Ramos MJ (2004b) Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine. J Comp Chem 25:1286\u20131294","journal-title":"J Comp Chem"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1021\/ja046662w","volume":"127","author":"S Pereira","year":"2005","unstructured":"Pereira S, Fernandes PA, Ramos MJ (2005) Theoretical study on the inhibition of ribonucleotide reductase by 2\u2019-mercapto-2\u2019-deoxyribonucleoside-5\u2019-diphosphates. J Am Chem Soc 127:5174\u20135179","journal-title":"J Am Chem Soc"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"31533","DOI":"10.1074\/jbc.272.50.31533","volume":"272","author":"AL Persson","year":"1997","unstructured":"Persson AL, Eriksson M, Katterle B, P\u00f6tsh S, Sahlin M, Sj\u00f6berg B-M (1997) A new mechanism-based radical intermediate in a mutant R1 protein affecting the catalytically essential Glu441 in Escherichia coli ribonucleotide reductase. J Biol Chem 272:31533\u201331541","journal-title":"J Biol Chem"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1126\/science.8511586","volume":"260","author":"P Reichard","year":"1993","unstructured":"Reichard P (1993) From RNA to DNA, why so many ribonucleotide reductases? Science 260:1773\u20131777","journal-title":"Science"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1592\/phco.19.3.196.30913","volume":"19","author":"F Romanelli","year":"1999","unstructured":"Romanelli F, Pomeroy C, Smith KM (1999) Hydroxyurea to inhibit human immunodeficiency virus-1 replication. Pharmacotherapy 19:196\u2013204","journal-title":"Pharmacotherapy"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1021\/ja9736065","volume":"120","author":"PEM Siegbahn","year":"1998","unstructured":"Siegbahn PEM (1998) Theoretical study of the substrate mechanism of ribonuleotide reductase. J Am Chem Soc 120:8417\u20138429","journal-title":"J Am Chem Soc"},{"key":"26_CR34","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/ic981332w","volume":"38","author":"PEM Siegbahn","year":"1999","unstructured":"Siegbahn PEM (1999) Theoretical model studies of the iron dimer complex of MMO and RNR. Inorg Chem 38:2880\u20132889","journal-title":"Inorg Chem"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s002140050264","volume":"97","author":"PEM Siegbahn","year":"1997","unstructured":"Siegbahn PEM, Blomberg MRA, Crabtree RH (1997) Hydrogen transfer in the presence of amino acid radicals. Theor Chem Acc 97:289\u2013300","journal-title":"Theor Chem Acc"},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-2614(98)00688-5","volume":"292","author":"PEM Siegbahn","year":"1998","unstructured":"Siegbahn PEM, Blomberg MRA, Pavlov M (1998a) A comparison of electron transfer in ribonucleotide reductase and the bacterial photosynthetic reaction center. Chem Phys Lett 292:421\u2013430","journal-title":"Chem Phys Lett"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"10622","DOI":"10.1021\/jp9827835","volume":"102","author":"PEM Siegbahn","year":"1998","unstructured":"Siegbahn PEM, Eriksson L, Himo F, Pavlov M (1998b) Hydrogen atom transfer in ribonucleotide reductase (RNR). J Phys Chem B 102:10622\u201310629","journal-title":"J Phys Chem B"},{"key":"26_CR38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cr9400875","volume":"98","author":"J Stubbe","year":"1998","unstructured":"Stubbe J, van Der Donk WA (1998) Protein radicals in enzyme catalysis. Chem Rev 98:705\u2013762","journal-title":"Chem Rev"},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1021\/ja960399k","volume":"118","author":"BE Sturgeon","year":"1996","unstructured":"Sturgeon BE, Burdi D, Chen S, Huynh B-H, Edmondson DE, Stubbe J, Hoffman BM (1996) Reconsideration of X, the diiron intermediate formed during cofactor assembly in E. coli ribonucleotide reductase. J Am Chem Soc 118:7551\u20137557","journal-title":"J Am Chem Soc"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1021\/jp003692m","volume":"105","author":"M Torrent","year":"2001","unstructured":"Torrent M, Musaev DG, Morokuma K (2001) The flexibility of carboxylate ligands in methane monooxygenase and ribonucleotide reductase: a density functional study. J Phys Chem B 105:322\u2013327","journal-title":"J Phys Chem B"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcc.1157","volume":"23","author":"M Torrent","year":"2002","unstructured":"Torrent M, Musaev DG, Basch H, Morokuma K (2002) Computational studies of reaction mechanisms of methane monooxygenase and ribonucleotide reductase. J Comp Chem 23:59\u201376","journal-title":"J Comp Chem"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3816\/CBC.2002.s.010","volume":"3","author":"D Tripathy","year":"2002","unstructured":"Tripathy D. (2002) Gemcitabine in breast cancer: future directions. Clin Breast Cancer 3:45\u201348","journal-title":"Clin Breast Cancer"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1586\/14737140.2.4.437","volume":"2","author":"AM Tsimberidou","year":"2002","unstructured":"Tsimberidou AM, Alvarado Y, Giles FJ (2002) Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies. Expert Rev Anticancer Ther 2:437\u2013448","journal-title":"Expert Rev Anticancer Ther"},{"key":"26_CR44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/370533a0","volume":"370","author":"U Uhlin","year":"1994","unstructured":"Uhlin U, Eklund H (1994) Structure of ribonucleotide reductase protein R1. Nature 370:533\u2013539","journal-title":"Nature"},{"key":"26_CR45","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1021\/ja0374731","volume":"126","author":"PP Wei","year":"2004","unstructured":"Wei PP, Skulan AJ, Mitic N, Yang YS, Saleh L, Bollinger JM, Solomon EI (2004) Electronic and spectroscopic studies of the non-heme reduced binuclear iron sites of two ribonucleotide reductase variants: comparison to reduced methane monooxygenase and contributions to O2 reactivity. J Am Chem Soc 126:3777\u20133788","journal-title":"J Am Chem Soc"},{"key":"26_CR46","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1021\/ja994406r","volume":"122","author":"Y-S Yang","year":"2000","unstructured":"Yang Y-S, Baldwin J, Ley BA, Bollinger JM Jr, Solomon EI (2000) Spectroscopic and electronic structure description of the reduced binuclear non-heme iron active site in ribonucleotide reductase from E. coli: comparison to reduced \u03949 desaturase and electronic structure contributions to differences in O2 reactivity. J Am Chem Soc 122:8495\u20138510","journal-title":"J Am Chem Soc"}],"container-title":["European Biophysics Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00249-005-0026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00249-005-0026-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00249-005-0026-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T14:48:55Z","timestamp":1558709335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00249-005-0026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,29]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s00249-005-0026-6","relation":{},"ISSN":["0175-7571","1432-1017"],"issn-type":[{"value":"0175-7571","type":"print"},{"value":"1432-1017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,29]]}}}